Thomas Flaten
Stock Analyst at Lake Street
(0.62)
# 2,973
Out of 4,412 analysts
28
Total ratings
22.22%
Success rate
-25.49%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DMTK DermTech | Downgrades: Hold | $0.63 | $0.60 | +4.46% | 1 | Apr 19, 2024 | |
| OPTN OptiNose | Maintains: Buy | $3 → $4 | $0.86 | +364.90% | 2 | Mar 18, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.83 | +262.23% | 3 | Mar 12, 2024 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $3 → $8 | $4.07 | +96.56% | 1 | Mar 7, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $4.61 | +138.61% | 3 | Mar 5, 2024 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $16 → $14 | $1.43 | +879.02% | 3 | Aug 16, 2023 | |
| BTTX Better Therapeutics | Maintains: Buy | $5 → $3 | $0.01 | +29,900.00% | 2 | Aug 10, 2023 | |
| BLFS BioLife Solutions | Maintains: Buy | $34 → $25 | $17.53 | +42.61% | 2 | Aug 9, 2023 | |
| CSTL Castle Biosciences | Reiterates: Buy | $32 | $20.34 | +57.33% | 4 | Jul 7, 2023 | |
| EVAX Evaxion Biotech | Maintains: Buy | $180 → $70 | $4.18 | +1,574.64% | 1 | Mar 31, 2023 | |
| OCX OncoCyte | Downgrades: Hold | $60 → $10 | $2.48 | +303.23% | 3 | Dec 1, 2022 | |
| ENSC Ensysce Biosciences | Maintains: Buy | $960 → $96 | $0.58 | +16,332.73% | 2 | Nov 17, 2022 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $14 → $8 | $2.57 | +211.28% | 1 | Jul 7, 2022 |
DermTech
Apr 19, 2024
Downgrades: Hold
Price Target: $0.63
Current: $0.60
Upside: +4.46%
OptiNose
Mar 18, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $0.86
Upside: +364.90%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.83
Upside: +262.23%
Aquestive Therapeutics
Mar 7, 2024
Maintains: Buy
Price Target: $3 → $8
Current: $4.07
Upside: +96.56%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.61
Upside: +138.61%
Checkpoint Therapeutics
Aug 16, 2023
Maintains: Buy
Price Target: $16 → $14
Current: $1.43
Upside: +879.02%
Better Therapeutics
Aug 10, 2023
Maintains: Buy
Price Target: $5 → $3
Current: $0.01
Upside: +29,900.00%
BioLife Solutions
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $17.53
Upside: +42.61%
Castle Biosciences
Jul 7, 2023
Reiterates: Buy
Price Target: $32
Current: $20.34
Upside: +57.33%
Evaxion Biotech
Mar 31, 2023
Maintains: Buy
Price Target: $180 → $70
Current: $4.18
Upside: +1,574.64%
OncoCyte
Dec 1, 2022
Downgrades: Hold
Price Target: $60 → $10
Current: $2.48
Upside: +303.23%
Ensysce Biosciences
Nov 17, 2022
Maintains: Buy
Price Target: $960 → $96
Current: $0.58
Upside: +16,332.73%
DiaMedica Therapeutics
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $2.57
Upside: +211.28%